top of page

Should Physicians Worry About Sunshine Act Reporting When Taking on a Side Gig?

2 hours ago
8 min read

Most side gigs that physicians in our online communities for doctors engage in don’t require telling anybody except the IRS how much revenue is generated. However, there are some entities that offer payments to doctors that are in highly regulated industries which require not just reporting, but visibility to the public. The most common examples of these include medical survey and consulting work that involve pharmaceutical companies, medical device companies, and medical supply manufacturers. Below, we’ll cover what the Sunshine Act is, what gets reported, whether it’s a big deal to patients and others who view this information, and how you can decide whether having this information publicly online in a database is enough of a deterrent to prevent you from engaging in these side gigs.


Disclosure/Disclaimer: Our content is for generalized educational purposes.  While we try to ensure it is accurate and updated, we cannot guarantee it. We are not formal financial, legal, or tax professionals and do not provide individualized advice specific to your situation. You should consult these as appropriate and/or do your own due diligence before making decisions based on this page. To learn more, visit our disclaimers and disclosures.


What is the Sunshine Act? What it is, how it works, cautions, and what gets reported.


What is the Sunshine Act?


Chances are, if you’re a physician that has done a lot of medical surveys or consulting work, or if you routinely interact with pharma or medical device reps, you’ve come across the term "Sunshine Act." You may have been asked to sign something related to it, and wondered if accepting the free meal or a few hundred (or even a few thousand) dollars for a medical survey or consulting call could create a problem for your professional reputation.


The Physician Payments Sunshine Act (which was formally known as the Open Payments program), was established under the Affordable Care Act. The TLDR is that it requires many pharmaceutical, medical device, and medical supply manufacturers, as well as certain group purchasing organizations (GPOs), to report payments and other transfers of value made to physicians and other covered healthcare professionals.


Reportable transactions include:


  • Consulting fees and honoraria

  • Speaking engagements

  • Meals and entertainment

  • Travel and lodging

  • Research payments

  • Certain educational and other professional expenses


Note that this isn’t any engagements of these types - just ones that are conducted with the entities above.


This information is then collated into a centralized system through the Centers for Medicare & Medicaid Services (CMS), and made publicly searchable through the Open Payments database. Yes, this means that your patients can see it - if they’re looking for it.



Does this mean these payments are shady?


There is an important distinction to be made here. The Sunshine Act is a transparency requirement, NOT a prohibition on physicians earning money from industry-related activities. Just because you have a payment listed there doesn’t suggest that there was some type of inappropriate relationship, or even that the relationship compromises or impacts your medical judgment. 



How does this relate to me if I want to do more medical surveys and consulting side gigs?


There are so many different types of consulting and market research activities. Common ones we see on our communities are: 


  • Participating in a 25-minute medical market research survey

  • Completing a paid questionnaire about clinical workflows

  • Providing feedback on a medical device concept or prototype

  • Participating in an expert interview about treatment trends

  • Advising a healthcare technology company on product development


Note that not all of these are reportable via the Sunshine Act - even if they involve medical devices or pharmaceutical companies. Whether a payment is reportable depends on who ultimately funds the activity, the nature of the relationship, and the reporting rules that apply. There’s also an important caveat - the companies need to know who you are.


A lot of market research is conducted anonymously. CMS has actually specifically clarified that when an applicable manufacturer uses a market research company to conduct double-blinded research with physicians, and the arrangement is structured to preserve the anonymity of both the respondents and the sponsor, payments to participating physicians are not considered reportable indirect payments under the described circumstances.


That means not every paid medical survey automatically creates a Sunshine Act entry, even if it’s about a drug. However, you may see a qualifying question in the screener that gives permission to the company to report the payment if for some reason your identity was unblinded or if you wanted to further engage with the company in a way that would make you identifiable. The company will typically give you the option to opt out of the survey in this situation if it makes you uncomfortable, though it may result in screening out of the survey.


Consulting arrangements can be different. If a pharmaceutical or medical device manufacturer pays a physician directly for consulting, that payment will generally be reportable. Payments routed through an intermediary may also be reportable when the manufacturer directs or causes the payment to reach the physician. There are nuances to all of this, and the companies involved should be transparent with you about it.



Who actually tends to look up these payments?


While the database is public information and therefore anybody can access the information through a simple web search, in reality, this is rarely done. Most patients probably don’t look up their physician’s financial relationships. That said, some may look up the data when researching treatment options or evaluating potential conflicts of interest.


Other people or entities who may have an interest in your financial relationships and do access the Open Payments data include:


  • Journalists and researchers: Financial relationships can be relevant when investigating industry influence, medical research, prescribing patterns, or healthcare trends

  • Hospitals and healthcare organizations: Compliance departments, credentialing teams, and conflict-of-interest committees may review physician financial relationships.

  • Advocacy and watchdog organizations: Groups interested in pharmaceutical and medical device industry influence may analyze the database.

  • Other industry participants: Companies and competitors may also use publicly available information to understand industry relationships.



Even if they do look you up, does a few hundred or a few thousand in consulting or medical survey compensation really matter?


This is of course nuanced, and context matters. The important question isn't whether a payment exists (or even necessarily how large it is, because small payments could be problematic and large payments could be just fine, depending on the context), but whether the financial relationship could reasonably influence, or appear to influence, your professional judgment.


All patients are different, and some may care about a tiny payment of even a free lunch, whereas others may not bat an eyelash at things. There’s really no way to know for certain, but here are two examples worth considering as you decide what’s right for you.



Scenario 1: You’re paid $150 for doing a medical survey for market research, or $1500 for attending a 2 hour consulting feedback session on a new medical device


If you are being paid fair market value for your expertise and providing helpful input that helps shape the future of an industry that helps patients, it’s hard to believe that many people could make a big deal out of it. The numbers aren’t high enough to be jealousy inducing for most people, and these are generally rates that the public views as being in line with your opportunity costs as a busy physician. Many times, they’re also backed by Fair Market Value calculations.



Scenario 2: You’re paid $300,000 annually from a pharmaceutical company for doing occasional talks, and you routinely recommend their products on your social media channel


There’s a lot more people that may raise an eyebrow here, including potentially regulatory agencies if there’s thought to be a violation of healthcare laws such as anti-Kickback statutes. If there’s a feeling that the amount of money you’re being paid might influence the options you provide to your patients, your patients may care too. You may want to gut check yourself on whether you’d feel comfortable justifying these payments, as well as check with counsel as to whether they violate any healthcare laws.


PSG Resource:



When Could a Payment Actually Become a Conflict-of-Interest Concern?


Remember, you’re not usually doing anything wrong here, and you’re actually more likely to be paid a totally defensible amount when payments are being reported. Many payments that are reported to the Sunshine Act are also trying to stay within the guidelines or norms for Fair Market Value. You’re unlikely to be making an amount for an engagement that is vastly different than what your peers would make unless you have niche expertise as a key opinion leader or other defensible reason for a payment substantially different from your peers. 


A few scenarios do merit a second thought, though. Ask yourself about these themes:


  • Relevance to your clinical practice: Does the company make products that you prescribe, recommend, or use?

  • Size of the relationship: Is this occasional supplemental income or a substantial recurring source of compensation?

  • Nature of the work: Are you providing independent professional expertise, or are you being compensated to promote a particular product?

  • Transparency: Would you feel comfortable explaining the relationship to a patient, employer, or colleague? (we think this is a particularly good one everyone should ask!)

  • Institutional policies: Does your employer have disclosure requirements that apply regardless of whether the payment is reportable under the Sunshine Act? (important for those physicians who think they can do these engagements under the radar even if they are not permitted to by contract)



So, should I just play it safe and avoid anything that reports to the Sunshine Act?


This is a personal decision that only you can make for yourself based on how you think others may receive this information (and how much you care about how they receive it). That said, we’d urge you to put it into perspective before cutting out a line of side gigs that you are uniquely qualified to engage in.


Medical research, market research and medical surveys, speaking, and consulting are all great ways to not just make extra money, but also to advance the field. It’s important that physicians are at the table for healthcare innovation, and that involves giving feedback, as well as helping to shape solutions.


5 ways that a payment may become a conflict of interest, based on The Sunshine Act


Conclusion


Don't automatically let the Sunshine Act scare you away from legitimate opportunities that leverage your expertise and pay you appropriately for them - but listen to your gut. 


You’ve spent years developing specialized knowledge and clinical expertise, and you shouldn’t be ashamed of getting paid appropriately for it. The Sunshine Act exists to make certain financial relationships transparent, not to suggest that physicians should never accept compensation from healthcare companies. While transparency is important, accepting a payment is not synonymous with shady, and certainly doesn’t automatically compromise your integrity as a physician. Consider what you think the real consequences of a physician or someone else stumbling upon these payments would be, and then decide what’s right for you.



Related medical survey and consulting resources for physicians 


Sign up for our weekly newsletter for alerts about side gig opportunities, upcoming free webinars, new articles and podcast episodes, additional educational resources, and more.


Related PSG resources: 

bottom of page